Literature DB >> 15518245

Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism.

Kristin K Isaacs1, Marina V Evans, Thomas R Harris.   

Abstract

A physiologically based pharmacokinetic (PBPK) model incorporating mixed enzyme inhibition was used to determine the mechanism of metabolic interactions occurring during simultaneous exposures to the organic solvents chloroform and trichloroethylene (TCE). Visualization-based sensitivity and identifiability analyses of the model were performed to determine the conditions under which four inhibitory parameters describing inhibitor binding could be estimated. The sensitivity methods were used to reduce the 4-parameter estimation problem into two distinct 2-parameter problems. The inhibitory parameters were then estimated from multiple closed-chamber gas-uptake experiments using graphical methods. The estimated values of the four inhibitory parameters predicted that chloroform and TCE interact in a competitive manner. Based on the model analysis, we present recommendations for the design of experiments for determination of inhibition mechanism in binary chemical mixtures. We assert that a thorough analysis of the parameter-dependent sensitivity and identifiability characteristics can be used to plan efficient experimental protocols for the quantitative analysis of inhalation pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518245     DOI: 10.1023/b:jopa.0000039565.11358.94

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  12 in total

1.  Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling.

Authors:  I D Dobrev; M E Andersen; R S Yang
Journal:  Arch Toxicol       Date:  2001-05       Impact factor: 5.153

2.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

3.  Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.

Authors:  M V Evans; W D Crank; H M Yang; J E Simmons
Journal:  Toxicol Appl Pharmacol       Date:  1994-09       Impact factor: 4.219

4.  Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans.

Authors:  R Tardif; G Charest-Tardif; J Brodeur; K Krishnan
Journal:  Toxicol Appl Pharmacol       Date:  1997-05       Impact factor: 4.219

5.  Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice.

Authors:  A A Constan; C S Sprankle; J M Peters; G L Kedderis; J I Everitt; B A Wong; F L Gonzalez; B E Butterworth
Journal:  Toxicol Appl Pharmacol       Date:  1999-10-15       Impact factor: 4.219

6.  A physiologically based simulation approach for determining metabolic constants from gas uptake data.

Authors:  M L Gargas; M E Andersen; H J Clewell
Journal:  Toxicol Appl Pharmacol       Date:  1986-12       Impact factor: 4.219

7.  Development of a physiologically based pharmacokinetic model for chloroform.

Authors:  R A Corley; A L Mendrala; F A Smith; D A Staats; M L Gargas; R B Conolly; M E Andersen; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1990-05       Impact factor: 4.219

8.  Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.

Authors:  C E Dallas; J M Gallo; R Ramanathan; S Muralidhara; J V Bruckner
Journal:  Toxicol Appl Pharmacol       Date:  1991-09-01       Impact factor: 4.219

9.  Physiologically based modeling of the toxicokinetic interaction between toluene and m-xylene in the rat.

Authors:  R Tardif; S Laparé; K Krishnan; J Brodeur
Journal:  Toxicol Appl Pharmacol       Date:  1993-06       Impact factor: 4.219

Review 10.  Metabolism of trichloroethylene.

Authors:  L H Lash; J W Fisher; J C Lipscomb; J C Parker
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.